用于患有注意力缺陷/多动障碍的学龄前儿童的哌甲酯透皮系统 - Suppr | 超能文献

Methylphenidate transdermal system in preschool children with attention-deficit/hyperactivity disorder.

作者信息

Ghuman Jaswinder Kaur, Byreddy Seenaiah, Ghuman Harinder Singh

出版信息

J Child Adolesc Psychopharmacol. 2011 Oct;21(5):495-8. doi: 10.1089/cap.2011.0049.

DOI:10.1089/cap.2011.0049

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Methylphenidate transdermal system in preschool children with attention-deficit/hyperactivity disorder.用于患有注意力缺陷/多动障碍的学龄前儿童的哌甲酯透皮系统

J Child Adolesc Psychopharmacol. 2011 Oct;21(5):495-8. doi: 10.1089/cap.2011.0049.

2

A controlled trial of the methylphenidate transdermal system on before-school functioning in children with attention-deficit/hyperactivity disorder.一项关于哌醋甲酯透皮贴剂对注意缺陷多动障碍儿童上学前功能影响的对照试验。

J Clin Psychiatry. 2010 May;71(5):548-56. doi: 10.4088/JCP.09m05779pur.

3

Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder.哌醋甲酯透皮贴剂：用于注意缺陷多动障碍的临床应用。

Expert Rev Clin Pharmacol. 2011 May;4(3):311-28. doi: 10.1586/ecp.11.11.

4

Efficacy of a methylphenidate transdermal system versus t.i.d. methylphenidate in a laboratory setting.在实验室环境下，哌醋甲酯透皮系统与tid 哌醋甲酯的疗效比较。

J Atten Disord. 2011 Jan;15(1):28-35. doi: 10.1177/1087054709359163. Epub 2010 May 3.

5

Single- and multiple-dose pharmacokinetics of methylphenidate administered as methylphenidate transdermal system or osmotic-release oral system methylphenidate to children and adolescents with attention deficit hyperactivity disorder.注意缺陷多动障碍儿童和青少年中单剂量和多剂量哌醋甲酯透皮系统或渗透型口服溶液给药的药代动力学。

J Clin Psychopharmacol. 2010 Oct;30(5):554-64. doi: 10.1097/JCP.0b013e3181f0c2f6.

6

Methylphenidate transdermal system.哌甲酯透皮贴剂

J Am Acad Child Adolesc Psychiatry. 2005 Dec;44(12):1223. doi: 10.1097/01.chi.0000183461.18907.bc.

7

Methylphenidate transdermal system in adult ADHD and impact on emotional and oppositional symptoms.哌醋甲酯透皮贴剂治疗成人 ADHD 及其对情绪和对立症状的影响。

J Atten Disord. 2011 May;15(4):295-304. doi: 10.1177/1087054710365986. Epub 2010 Apr 21.

8

Transdermal methylphenidate (Daytrana) for ADHD.用于治疗注意力缺陷多动障碍的透皮哌甲酯（Daytrana）。

Med Lett Drugs Ther. 2006 Jun 19;48(1237):49-51.

9

Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.透皮哌甲酯、行为疗法及联合治疗用于多动症儿童

Exp Clin Psychopharmacol. 2005 May;13(2):111-26. doi: 10.1037/1064-1297.13.2.111.

10

Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.哌甲酯透皮系统在儿童注意力缺陷/多动障碍中的长期耐受性：一项多中心、前瞻性、为期12个月的开放标签、非对照、四项临床试验的III期扩展研究。

Clin Ther. 2009 Aug;31(8):1844-55. doi: 10.1016/j.clinthera.2009.08.002.

引用本文的文献

1

Pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: clinical strategies.儿童和青少年注意力缺陷多动障碍的药物治疗：临床策略

J Cent Nerv Syst Dis. 2012 Dec 20;5:1-17. doi: 10.4137/JCNSD.S6691. Print 2013.

2

Pharmacologic intervention for attention-deficit hyperactivity disorder in preschoolers : is it justified?学龄前儿童注意缺陷多动障碍的药物干预：合理吗？

Paediatr Drugs. 2013 Feb;15(1):1-8. doi: 10.1007/s40272-012-0001-5.